Home
Oxygenta Pharmaceutical Ltd Board of Directors
Board of Directors at Oxygenta Pharmaceutical Ltd
Additional Director
Additional Director
Independent Director
Company Sec. & Compli. Officer
Executive Director
Key Highlights
- Sai Sudhakar Vankineni continues to serve as the Chairman & Managing Director in 2024, maintaining the same position as in the previous year.
- Sangari Kondal Reddy continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- Padmaja Surapureddy continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
- Kanuganti Raghavender Rao joins the board as Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Sravani Reddy Gantla joins the board as Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Oxygenta Pharmaceutical Ltd
NSE: OXYGENTAPHARMA
Share Price
Last Ten Days Market Price
Date | |
---|---|
13 Mar 2025 | 77.43 |
12 Mar 2025 | 79.01 |
11 Mar 2025 | 79.4 |
10 Mar 2025 | 77.87 |
07 Mar 2025 | 76.35 |
06 Mar 2025 | 74.86 |
05 Mar 2025 | 73.4 |
04 Mar 2025 | 71.97 |
03 Mar 2025 | 73.43 |
28 Feb 2025 | 74.92 |
Company Fundamentals for Oxygenta Pharmaceutical Ltd
Market Cap
286 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
0.0
Day’s High
78.62
Day’s Low
77.43
DTE
-2.9
ROE
-0.1
52 Week High
108.64
52 Week Low
27.62
ROCE
-24.5
Market Price of Oxygenta Pharmaceutical Ltd
1M
1Y
3Y
5Y
Oxygenta Pharmaceutical Ltd News Hub
Oxygenta Pharmaceutical reports standalone net loss of Rs 1.36 crore in the June 2024 quarter
Net Loss of Oxygenta Pharmaceutical reported to Rs 1.36 crore in the quarter ended June 2024 as agai
Read more
16 Aug 24
Oxygenta Pharmaceutical to discuss results
Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 August 20
Read more
12 Aug 24
Oxygenta Pharmaceutical schedules AGM
Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the company will be
Read more
18 Sept 24
Oxygenta Pharmaceutical announces board meeting date
Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 November
Read more
11 Nov 24